Cargando…

Anti-MuSK Antibody-positive Myasthenia Gravis Successfully Treated with Outpatient Periodic Weekly Blood Purification Therapy

A 37-year-old man with anti-muscle-specific tyrosine kinase (MuSK) antibody-positive myasthenia gravis (MG) presented with subacute progressive dysphagia and muscle weakness of the neck and bilateral upper extremities. Conventional immune-suppressive treatments and high-dose intravenous immunoglobul...

Descripción completa

Detalles Bibliográficos
Autores principales: Deguchi, Kentaro, Matsuzono, Kosuke, Nakano, Yumiko, Kono, Syoichiro, Sato, Kota, Deguchi, Shoko, Tanabe, Katsuyuki, Hishikawa, Nozomi, Ota, Yasuyuki, Yamashita, Toru, Ohta, Kiyoe, Motomura, Masakatsu, Abe, Koji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5995714/
https://www.ncbi.nlm.nih.gov/pubmed/29321424
http://dx.doi.org/10.2169/internalmedicine.9466-17
_version_ 1783330651768881152
author Deguchi, Kentaro
Matsuzono, Kosuke
Nakano, Yumiko
Kono, Syoichiro
Sato, Kota
Deguchi, Shoko
Tanabe, Katsuyuki
Hishikawa, Nozomi
Ota, Yasuyuki
Yamashita, Toru
Ohta, Kiyoe
Motomura, Masakatsu
Abe, Koji
author_facet Deguchi, Kentaro
Matsuzono, Kosuke
Nakano, Yumiko
Kono, Syoichiro
Sato, Kota
Deguchi, Shoko
Tanabe, Katsuyuki
Hishikawa, Nozomi
Ota, Yasuyuki
Yamashita, Toru
Ohta, Kiyoe
Motomura, Masakatsu
Abe, Koji
author_sort Deguchi, Kentaro
collection PubMed
description A 37-year-old man with anti-muscle-specific tyrosine kinase (MuSK) antibody-positive myasthenia gravis (MG) presented with subacute progressive dysphagia and muscle weakness of the neck and bilateral upper extremities. Conventional immune-suppressive treatments and high-dose intravenous immunoglobulin were ineffective. He then displayed repeated exacerbations and remissions over the course of two years, despite two to four sessions of plasma exchange (PE) every two months. The patient was successfully treated with outpatient periodic weekly blood purification therapy with alternative PE and double-filtration plasmapheresis using an internal shunt. This case report suggests the benefits of blood purification therapy with an internal shunt against anti-MuSK antibody-positive MG.
format Online
Article
Text
id pubmed-5995714
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher The Japanese Society of Internal Medicine
record_format MEDLINE/PubMed
spelling pubmed-59957142018-06-13 Anti-MuSK Antibody-positive Myasthenia Gravis Successfully Treated with Outpatient Periodic Weekly Blood Purification Therapy Deguchi, Kentaro Matsuzono, Kosuke Nakano, Yumiko Kono, Syoichiro Sato, Kota Deguchi, Shoko Tanabe, Katsuyuki Hishikawa, Nozomi Ota, Yasuyuki Yamashita, Toru Ohta, Kiyoe Motomura, Masakatsu Abe, Koji Intern Med Case Report A 37-year-old man with anti-muscle-specific tyrosine kinase (MuSK) antibody-positive myasthenia gravis (MG) presented with subacute progressive dysphagia and muscle weakness of the neck and bilateral upper extremities. Conventional immune-suppressive treatments and high-dose intravenous immunoglobulin were ineffective. He then displayed repeated exacerbations and remissions over the course of two years, despite two to four sessions of plasma exchange (PE) every two months. The patient was successfully treated with outpatient periodic weekly blood purification therapy with alternative PE and double-filtration plasmapheresis using an internal shunt. This case report suggests the benefits of blood purification therapy with an internal shunt against anti-MuSK antibody-positive MG. The Japanese Society of Internal Medicine 2018-01-11 2018-05-15 /pmc/articles/PMC5995714/ /pubmed/29321424 http://dx.doi.org/10.2169/internalmedicine.9466-17 Text en Copyright © 2018 by The Japanese Society of Internal Medicine https://creativecommons.org/licenses/by-nc-nd/4.0/ The Internal Medicine is an Open Access article distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. To view the details of this license, please visit (https://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Case Report
Deguchi, Kentaro
Matsuzono, Kosuke
Nakano, Yumiko
Kono, Syoichiro
Sato, Kota
Deguchi, Shoko
Tanabe, Katsuyuki
Hishikawa, Nozomi
Ota, Yasuyuki
Yamashita, Toru
Ohta, Kiyoe
Motomura, Masakatsu
Abe, Koji
Anti-MuSK Antibody-positive Myasthenia Gravis Successfully Treated with Outpatient Periodic Weekly Blood Purification Therapy
title Anti-MuSK Antibody-positive Myasthenia Gravis Successfully Treated with Outpatient Periodic Weekly Blood Purification Therapy
title_full Anti-MuSK Antibody-positive Myasthenia Gravis Successfully Treated with Outpatient Periodic Weekly Blood Purification Therapy
title_fullStr Anti-MuSK Antibody-positive Myasthenia Gravis Successfully Treated with Outpatient Periodic Weekly Blood Purification Therapy
title_full_unstemmed Anti-MuSK Antibody-positive Myasthenia Gravis Successfully Treated with Outpatient Periodic Weekly Blood Purification Therapy
title_short Anti-MuSK Antibody-positive Myasthenia Gravis Successfully Treated with Outpatient Periodic Weekly Blood Purification Therapy
title_sort anti-musk antibody-positive myasthenia gravis successfully treated with outpatient periodic weekly blood purification therapy
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5995714/
https://www.ncbi.nlm.nih.gov/pubmed/29321424
http://dx.doi.org/10.2169/internalmedicine.9466-17
work_keys_str_mv AT deguchikentaro antimuskantibodypositivemyastheniagravissuccessfullytreatedwithoutpatientperiodicweeklybloodpurificationtherapy
AT matsuzonokosuke antimuskantibodypositivemyastheniagravissuccessfullytreatedwithoutpatientperiodicweeklybloodpurificationtherapy
AT nakanoyumiko antimuskantibodypositivemyastheniagravissuccessfullytreatedwithoutpatientperiodicweeklybloodpurificationtherapy
AT konosyoichiro antimuskantibodypositivemyastheniagravissuccessfullytreatedwithoutpatientperiodicweeklybloodpurificationtherapy
AT satokota antimuskantibodypositivemyastheniagravissuccessfullytreatedwithoutpatientperiodicweeklybloodpurificationtherapy
AT deguchishoko antimuskantibodypositivemyastheniagravissuccessfullytreatedwithoutpatientperiodicweeklybloodpurificationtherapy
AT tanabekatsuyuki antimuskantibodypositivemyastheniagravissuccessfullytreatedwithoutpatientperiodicweeklybloodpurificationtherapy
AT hishikawanozomi antimuskantibodypositivemyastheniagravissuccessfullytreatedwithoutpatientperiodicweeklybloodpurificationtherapy
AT otayasuyuki antimuskantibodypositivemyastheniagravissuccessfullytreatedwithoutpatientperiodicweeklybloodpurificationtherapy
AT yamashitatoru antimuskantibodypositivemyastheniagravissuccessfullytreatedwithoutpatientperiodicweeklybloodpurificationtherapy
AT ohtakiyoe antimuskantibodypositivemyastheniagravissuccessfullytreatedwithoutpatientperiodicweeklybloodpurificationtherapy
AT motomuramasakatsu antimuskantibodypositivemyastheniagravissuccessfullytreatedwithoutpatientperiodicweeklybloodpurificationtherapy
AT abekoji antimuskantibodypositivemyastheniagravissuccessfullytreatedwithoutpatientperiodicweeklybloodpurificationtherapy